{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:46:32Z","timestamp":1753890392561,"version":"3.41.2"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ebm-journal.org"],"crossmark-restriction":true},"short-container-title":["Exp. Biol. Med."],"abstract":"<jats:p>Cannabis and cannabinoid mixtures have been linked to a variety of health benefits including pain mitigation, suppression of nausea produced by chemotherapeutic agents, anti-inflammatory effects, and effects on energy homeostasis, glucose, and lipid metabolism. The latter properties have led to the suggestion that these products could have therapeutic effects on the development of metabolic dysfunction-associated steatohepatitis (MASH) - a severe type of liver pathology in obese and diabetic patients. However, varying agonist and antagonistic properties of different cannabinoids on the endogenous cannabinoid system make prediction regarding hepatic effects and diet interactions difficult. The current study was designed to examine hepatic pathology following chronic administration of a cannabinoid mixture (NEPE14) at a dose equivalent to one previously demonstrating antihyperalgesic effects in rats. The effects of NEPE14 were investigated in a mouse model of MASH produced by feeding a Western diet rich in fat and simple sugars. After 24 weeks of NEPE14 administration, there was no hepatotoxicity in mice receiving the control diet and no significant exacerbation of MASH in mice receiving the Western diet. In conclusion, no chronic liver toxicity was observed, but there was also no evidence for protection against MASH by this product.<\/jats:p>","DOI":"10.3389\/ebm.2025.10356","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T05:10:07Z","timestamp":1747631407000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronic administration of a cannabis-derived mixture at an antihyperalgesic dose does not significantly enhance hepatotoxicity or the development of metabolic dysfunction-associated steatohepatitis in male mice"],"prefix":"10.3389","volume":"250","author":[{"given":"Kim B.","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomislav","family":"Jelesijevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara M.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah M.","family":"Melton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley S.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Glenn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J.","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J. J.","family":"Ronis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Winsauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrn3811","article-title":"Early phytocannabinoid chemistry to endocannabinoids and beyond","volume":"15","author":"Mechoulam","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1172\/jci23057","article-title":"Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity","volume":"115","author":"Osei-Hyiaman","year":"2005","journal-title":"J Clin Invest"},{"key":"B3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ijo.2012.116","article-title":"CB1 blockade-induced weight loss over 48 weeks decreases liver fat in proportion to weight loss in humans","volume":"37","author":"Bergholm","year":"2013","journal-title":"Int J Obes"},{"key":"B4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1053\/j.gastro.2020.03.087","article-title":"Role of cannabis and its derivatives in gastrointestinal and hepatic disease","volume":"159","author":"Gotfried","year":"2020","journal-title":"Gastroenterology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1178638819847480","DOI":"10.1177\/1178638819847480","article-title":"Potential mechanisms influencing the inverse relationship between cannabis and nonalcoholic fatty liver disease: a commentary","volume":"12","author":"Dibba","year":"2019","journal-title":"Nutr Metab Insights"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/can.2022.0014","article-title":"Expanding research on cannabis-based medicines for liver steatosis: a low-risk high-reward way out of the present deadlock?","volume":"8","author":"Barr\u00e9","year":"2023","journal-title":"Cannabis Cannabinoid Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br J Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejphar.2011.12.043","article-title":"Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A2A receptor","volume":"678","author":"Ribeiro","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1096\/fj.201600646r","article-title":"Cannabinoids, inflammation, and fibrosis","volume":"30","author":"Zurier","year":"2016","journal-title":"The FASEB J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1039\/d2fo03054c","article-title":"Integration of transcriptomics and metabonomics revealed the protective effects of hemp seed oil against methionine\u2013choline-deficient diet-induced non-alcoholic steatohepatitis in mice","volume":"14","author":"Gong","year":"2023","journal-title":"Food and Funct"},{"key":"B11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol and Hepatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.3390\/nu14245335","article-title":"Diet and risk of non-alcoholic fatty liver disease, cirrhosis, and liver cancer: a large prospective cohort study in UK biobank","volume":"14","author":"Guo","year":"2022","journal-title":"Nutrients"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1016\/j.cgh.2022.11.040","article-title":"Quantifying the negative impact of fast-food consumption on liver steatosis among United States adults with diabetes and obesity","volume":"21","author":"Kardashian","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"173692","DOI":"10.1016\/j.pbb.2023.173692","article-title":"Distinct antinociceptive and conditioned behavioral effects are produced by individual cannabinoids and a cannabis-derived mixture","volume":"235","author":"Morris","year":"2024","journal-title":"Pharmacol Biochem Behav"},{"key":"B15","doi-asserted-by":"publisher","first-page":"G666","DOI":"10.1152\/ajpgi.00213.2016","article-title":"A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition","volume":"312","author":"Krishnan","year":"2017","journal-title":"Am J Physiology-Gastrointestinal Liver Physiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death and Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"101428","DOI":"10.1016\/j.molmet.2021.101428","article-title":"CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing","volume":"57","author":"Zeng","year":"2022","journal-title":"Mol Metab"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1194\/jlr.r056705","article-title":"Recent insights into the biological functions of liver fatty acid binding protein 1","volume":"56","author":"Wang","year":"2015","journal-title":"J Lipid Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.bbalip.2012.12.014","article-title":"The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPAR\u03b1; and repressed by C\/EBP\u03b1: implications in FABP1 down-regulation in nonalcoholic fatty liver disease","volume":"1831","author":"Guzm\u00e1n","year":"2013","journal-title":"Biochim Biophys Acta (Bba) - Mol Cell Biol Lipids"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1021\/acs.biochem.6b00446","article-title":"FABP1: a novel hepatic endocannabinoid and cannabinoid binding protein","volume":"55","author":"Huang","year":"2016","journal-title":"Biochemistry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"7588","DOI":"10.1038\/s41598-019-44108-3","article-title":"FABP1 controls hepatic transport and biotransformation of \u0394(9)-THC","volume":"9","author":"Elmes","year":"2019","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.molimm.2021.03.005","article-title":"IFN-\u03b3 contributes to the hepatic inflammation in HFD-induced nonalcoholic steatohepatitis by STAT1\u03b2\/TLR2 signaling pathway","volume":"134","author":"Li","year":"2021","journal-title":"Mol Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"116069","DOI":"10.1016\/j.biopha.2023.116069","article-title":"Roles of immune dysregulation in MASLD","volume":"170","author":"Dong","year":"2024","journal-title":"Biomed and Pharmacother"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1111\/acer.13766","article-title":"Knockout of the Gsta4 gene in male mice leads to an altered pattern of hepatic protein carbonylation and enhanced inflammation following chronic consumption of an ethanol diet","volume":"42","author":"Shearn","year":"2018","journal-title":"Alcohol Clin Exp Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12944-020-01351-2","article-title":"Two weeks of western diet disrupts liver molecular markers of cholesterol metabolism in rats","volume":"19","author":"St-Amand","year":"2020","journal-title":"Lipids Health Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1124\/jpet.111.188540","article-title":"Sex differences in cannabinoid 1 vs. Cannabinoid 2 receptor-selective antagonism of antinociception produced by \u03949-tetrahydrocannabinol and CP55,940 in the rat","volume":"340","author":"Craft","year":"2012","journal-title":"The J Pharmacol Exp Ther"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2008.05.002","article-title":"Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation","volume":"595","author":"Patinkin","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.21037\/tcr.2019.05.32","article-title":"Hepatobiliary case report and literature review of hepatic reactive lymphoid hyperplasia with positive anti-smooth muscle antibody and anti-nuclear antibody tests","volume":"8","author":"Zheng","year":"2019","journal-title":"Transl Cancer Res"},{"key":"B29","article-title":"Oral NEPE14 mitigates skin wound combined radiation injury-induced hematopoietic impairment in mice","author":"Wang","year":"2021","journal-title":"Radiat Res Soc 67th Annu Int Meet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1038\/s41598-021-84674-z","article-title":"Hepatic lymphocytes involved in the pathogenesis of pediatric and adult non-alcoholic fatty liver disease","volume":"11","author":"Cairoli","year":"2021","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3390\/ijms20030668","article-title":"Cannabinoids reduce inflammation but inhibit lymphocyte recovery in murine models of bone marrow transplantation","volume":"20","author":"Khuja","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["Experimental Biology and Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.ebm-journal.org\/articles\/10.3389\/ebm.2025.10356\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T05:10:08Z","timestamp":1747631408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ebm-journal.org\/articles\/10.3389\/ebm.2025.10356\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":31,"alternative-id":["10.3389\/ebm.2025.10356"],"URL":"https:\/\/doi.org\/10.3389\/ebm.2025.10356","relation":{},"ISSN":["1535-3699"],"issn-type":[{"type":"electronic","value":"1535-3699"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"article-number":"10356"}}